Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022

Link-Gelles, R., Levy, M. E., Gaglani, M., Irving, S. A., Stockwell, M., Dascomb, K., DeSilva, M. B., Reese, S. E., Liao, I. C., Ong, T. C., Grannis, S. J., McEvoy, C., Patel, P., Klein, N. P., Hartmann, E., Stenehjem, E., Natarajan, K., Naleway, A. L., Murthy, K., Rao, S., … Tenforde, M. W. (2022). Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. MMWR. Morbidity and mortality weekly report, 71(29), 931–939. https://doi.org/10.15585/mmwr.mm7129e1

Authors:
Ruth Link-Gelles
Palak Patel
Monica Dickerson
Mark G. Thompson
Mark W. Tenforde
Matthew E. Levy
Sarah E. Reese
Akintunde Akinseye
Margaret M. Dunne
Sarah W. Ball
Manjusha Gaglani
I-Chia Liao
Kempapura Murthy
Deepika Konatham
Chandni Raiyani
Stephanie A. Irving
Allison L. Naleway
Melissa Stockwell
Karthik Natarajan
Kristin Dascomb
Edward Stenehjem
Nancy Grisel
Julie Arndorfer
Malini B. DeSilva
Charlene McEvoy
Toan C. Ong
Suchitra Rao
Michelle A. Barron
Shaun J. Grannis
Brian E. Dixon
William F. Fadel
Nimish R. Valvi
Nicola P. Klein
Ned Lewis
Kristin Goddard
Bruce Fireman
Ousseny Zerbo
Emily Hartmann
J. C. Currey
Chantel Sloan-Aagard
Jungmi Han
Anupam B. Kharbanda
Affiliated Authors:
Melissa Stockwell
Karthik Natarajan
Jungmi Han
Publication Type:
Article
Unique ID:
35862287
PMID:
Publication Date:
Data Source:
Web of Science

Record Created: